Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)
-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section A

Name:	us-gaap_DeferredRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 13.A.4(a).Q1)
-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section A

Name:	us-gaap_DeferredRevenueCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Represents the value established as the selling price of the significant unit of accounting used to allocate the consideration of the multiple-deliverable arrangement.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 25
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=51671369&loc=SL6750900-111635

Name:	us-gaap_RevenueRecognitionMultipleDeliverableArrangementsDeterminationOfSellingPriceAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the revenue earned during the period pertaining to collaborations, licenses and milestones.

No definition available.

Name:	xncr_CollaborationsLicensesAndMilestonesRevenue
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the number of antibody molecules for which bispecific technology applied, subject to company's approval.

No definition available.

Name:	xncr_CollaborativeAgreementBispecificTechnologyAppliedNumberOfAntibodyMolecules
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of antibody targets for which bispecific technology applied.

No definition available.

Name:	xncr_CollaborativeAgreementBispecificTechnologyAppliedNumberOfAntibodyTargets
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of delivery of targets for which bispecific technology applied.

No definition available.

Name:	xncr_CollaborativeAgreementBispecificTechnologyAppliedNumberOfTargetsDelivered
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of FC technology targets for which non-exclusive license is provided.

No definition available.

Name:	xncr_CollaborativeAgreementNonExclusiveLicenseProvidedNumberOfFcTechnologiesTargets
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of programs under the collaborative agreements.

No definition available.

Name:	xncr_CollaborativeAgreementNumberOfPrograms
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the percentage of profit on net sales of the product, if the company elects to participate in development.

No definition available.

Name:	xncr_CollaborativeAgreementPercentageOfProfitOnNetSales
Namespace Prefix:	xncr_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Represents the percentage of responsibility assumed for commercialization costs, if the company elects to participate in development.

No definition available.

Name:	xncr_CollaborativeAgreementPercentageOfResponsibilityAssumedForCommercializationCosts
Namespace Prefix:	xncr_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Represents the percentage of responsibility assumed for development costs, if the company elects to participate in development.

No definition available.

Name:	xncr_CollaborativeAgreementPercentageOfResponsibilityAssumedForDevelopmentCosts
Namespace Prefix:	xncr_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Represents the additional period for which research term may be extended under the collaborative agreement.

No definition available.

Name:	xncr_CollaborativeArrangementAdditionalResearchTerm
Namespace Prefix:	xncr_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the amount of nonrefundable upfront fees as provided under the collaboration agreement.

No definition available.

Name:	xncr_CollaborativeArrangementAnnualMaintenanceFees
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the amount of annual maintenance fees payable during any extension of research term under the collaboration agreement.

No definition available.

Name:	xncr_CollaborativeArrangementAnnualMaintenanceFeesDuringExtensionOfResearchTerm
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the amount of extension fees for extension of research term under the collaboration agreement.

No definition available.

Name:	xncr_CollaborativeArrangementExtensionFee
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the amount of nonrefundable upfront fee allocated to option under the collaboration agreement.

No definition available.

Name:	xncr_CollaborativeArrangementNonrefundableUpfrontFeeAllocatedToOption
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Represents the amount of nonrefundable upfront fees as provided under the collaboration agreement.

No definition available.

Name:	xncr_CollaborativeArrangementNonrefundableUpfrontFees
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the number of compounds.

No definition available.

Name:	xncr_CollaborativeArrangementNumberOfCompounds
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of different target programs under the collaborative agreement.

No definition available.

Name:	xncr_CollaborativeArrangementNumberOfTargetPrograms
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the amount of option fee that must be paid by counterparty with respect to each target for which the option is exercised as per the terms of the collaboration agreement.

No definition available.

Name:	xncr_CollaborativeArrangementOptionFee
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the research license term under the collaborative agreement.

No definition available.

Name:	xncr_CollaborativeArrangementResearchLicenseTerm
Namespace Prefix:	xncr_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the number of discover programs delivered.

No definition available.

Name:	xncr_NumberOfDeliveredDiscoverPrograms
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of development stage products that incorporate the company's bispecific Fc technology.

No definition available.

Name:	xncr_NumberOfDevelopmentStageProducts
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents information pertaining to the previously identified programs that can be substituted during the research term provided Amgen has not initiated non human primate studies

No definition available.

Name:	xncr_NumberOfPreviousIdentifiedProductsInWhichSubstitutionCanOccur
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of substitution rights.

No definition available.

Name:	xncr_NumberOfSubstitutionRights
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents information in which bispecific technology will be applied to previous targets

No definition available.

Name:	xncr_PreviousTargetsWhichBispecificTechnologyWillBeApplied
Namespace Prefix:	xncr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

Period over which revenue is recognized under the agreement

No definition available.

Name:	xncr_RevenueRecognitionContractPeriod
Namespace Prefix:	xncr_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the amount of consideration that will be recognized upon full completion of milestones set forth in a collaborative agreement between two parties.

No definition available.

Name:	xncr_RevenueRecognitionMilestoneMethodPending
Namespace Prefix:	xncr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Name:	us-gaap_TypeOfArrangementAxis=xncr_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xncr_MerckSharpAndDohmeCorpMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xncr_AlexionPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=xncr_OptionAndLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=xncr_CollaborationAndLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xncr_NovartisMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=xncr_Xmab14045ProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=xncr_Xmab13676ProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	xncr_CollaborationAndLicensingProgramsAxis=xncr_BispecificFcTechnologiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	xncr_CollaborationAndLicensingProgramsAxis=xncr_GlobalDiscoveryProgramMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	xncr_CollaborationAndLicensingProgramsAxis=xncr_FcLicensesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xncr_NovoNordiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=xncr_ResearchAndLicenseAgreement2015Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=xncr_AmgenIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	xncr_CollaborationAndLicensingProgramsAxis=xncr_Cd38ProgramMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	xncr_CollaborationAndLicensingProgramsAxis=xncr_DiscoveryProgramMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	xncr_PotentialMilestonesTypeAxis=xncr_DevelopmentBasedMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	xncr_PotentialMilestonesTypeAxis=xncr_RegulatoryBasedMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: